2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI in Action: Tucatinib (Tukysa®) Management – 2
Tucatinib (Tukysa®) Management – 2
About this PQI in Action
In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance resource for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the Tucatinib Management PQI and explores how the medically integrated teams at Johns Hopkins Kimmel Cancer Center – Sibley Memorial Hospital and Miami Cancer Institute incorporate PQIs as part of their daily workflow. This article will discuss how utilizing the Tucatinib Management PQI elevates patient care.
PQI in Action
PQI in Action: Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer
Last Updated: 01/12/2023 12:00 am
PQI
PQI: Tucatinib (TUKYSA®) and trastuzumab in HER2-positive Metastatic Colorectal Cancer
Last Updated: 08/01/2024 12:00 am